SlideShare is now on Android. 15 million presentations at your fingertips.  Get the app

×
  • Share
  • Email
  • Embed
  • Like
  • Private Content
 

Global Pharmaceutical Contract Manufacturing Market Injectable Dose Formulations Will Likely Spur the Growth of CMOs

by on Aug 29, 2013

  • 973 views

Cost benefits and pharmaceutical companies’ desire to focus on their core competencies has created an increasing need for outsourcing and spurred the global pharmaceutical contract manufacturing ...

Cost benefits and pharmaceutical companies’ desire to focus on their core competencies has created an increasing need for outsourcing and spurred the global pharmaceutical contract manufacturing market. Expiring blockbuster drug patents will reduce manufacturing capacity utilization rates and boost outsourcing further.

New analysis from Frost & Sullivan (http://www.lifesciences.frost.com), Global Pharmaceutical Contract Manufacturing Market, finds the market earned revenue of $13.43 billion in 2012 and estimates this to reach $18.49 billion in 2017. This research explores solid dose, liquid and semi-solid dose, and injectable dose formulations.

For more information on this analysis, please email Jennifer Carson, Corporate Communications, at jennifer.carson@frost.com, with your full name, company name, job title, telephone number, company e-mail address, company website, city, state and country.

Statistics

Views

Total Views
973
Views on SlideShare
973
Embed Views
0

Actions

Likes
1
Downloads
25
Comments
0

0 Embeds 0

No embeds

Accessibility

Upload Details

Uploaded via SlideShare as Adobe PDF

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
Post Comment
Edit your comment

Global Pharmaceutical Contract Manufacturing Market Injectable Dose Formulations Will Likely Spur the Growth of CMOs Global Pharmaceutical Contract Manufacturing Market Injectable Dose Formulations Will Likely Spur the Growth of CMOs Presentation Transcript